News

Our latest ALLG News Edition 10, is now available! Download a copy and learn about the impact ALLG’s clinical trial research has on patients with blood cancer. Hear from our supporters and their personal journeys of taking on challenges to raise money and awareness for blood cancer research – whether you’re one person or many, every dollar counts.

Discover more about ALLG’s role as Global Leaders with Global Impact through recognition of our innovative clinical trial results across the world. In 2024, we held two ALLG Scientific Meetings and a record number of twelve members presented their ALLG trial results at the 66th American Hematology Society Annual Meeting and Exhibition (this included four prestigious podium presentations and eight poster presentations).

ASH is the world’s largest haematology conference and research presented at ASH represents the most cutting-edge and significant research globally. These essential events allow haematologists to gather, discuss and share knowledge of how we as an organisation can deliver Better treatments…Better lives for patients with blood cancer.

ALLG’s innovative research continues to drive blood cancer breakthroughs as we work towards better treatments, better lives and potentially, a cure.

Read more by downloading our ALLG News, Edition 10.

 

ALLG News Edition 10 Insights

Read about ALLG’s progress in clinical trials throughout 2024, and how we are supporting and equipping the next generation of researchers who will continue to evolve, drive and deliver new blood cancer therapies to patients through our ALLG HSANZ Clinical Trials Fellowship Program.

Read about our work in developing teletrials that aim to provide equitable access to treatment for patients across rural and regional Australia. Teletrials use existing telehealth technology to create a network of clinical trial sites in areas outside of major cities and towns. For patients, this means less travel, less financial burden while accessing life-saving treatment closer to home.

Download ALLG News Edition 10 and stay up to date with innovative blood cancer trials and treatments by subscribing to ALLG News.

 

ALLG’s Impact – Blood Cancer Research

ALLG is Australasia’s only not-for-profit, collaborative blood cancer clinical trial group and over 50 years, ALLG has made an enormous impact on the way blood cancer is treated globally. In the last 12 months, our researchers have supported 1,061 patients and delivered a clinical trial portfolio of 75+ trials. ALLG’s membership base of 1,452 doctors and healthcare professionals are dedicated to developing and delivering clinical trial research to create Better treatments…Better lives for patients.

Research is the only way to advance blood cancer treatments, and clinical trials are the crucial link to bring promising new treatments from the lab directly to patients. Visit ALLG to learn more about our organisation and the many ways you can help support our research.